Analysis of blood stem cell activity and cystatin gene expression in a mouse model presenting a chromosomal deletion encompassing Csta and Stfa2l1

PLoS ONE

Volumn 4, Issue 10, 2009, Pages

  Bilodeau, Mélanie ^a   MacRae, Tara ^a   Gaboury, Louis ^a   Laverdure, Jean Philippe ^a   Hardy, Marie Pierre ^a   Mayotte, Nadine ^a   Paradis, Véronique ^a   Harton, Sébastien ^a   Perreault, Claude ^a,b,c   Sauvageau, Guy ^a,b,c  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATIN; PROTEIN CSTA; PROTEIN STFA1; PROTEIN STFA2; PROTEIN STFA2L1; PROTEIN STFA3; UNCLASSIFIED DRUG; CSTA PROTEIN, MOUSE; STEFIN A;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CARCINOGENESIS; CELL ACTIVITY; CELL CLONING; CHROMOSOME 16; CHROMOSOME DELETION; CONTROLLED STUDY; EMBRYONIC STEM CELL; FEMALE; FETUS LIVER; GENE EXPRESSION PROFILING; HEMATOPOIETIC STEM CELL; HOMOZYGOSITY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PHYLOGENY; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN; WILD TYPE; ALLELE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL SURVIVAL; CYTOLOGY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HOMOZYGOTE; STEM CELL;

ANIMALIA; MUS;

ALLELES; ANIMALS; CELL SURVIVAL; CHROMOSOME DELETION; CYSTATIN A; CYSTATINS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELLS; HOMOZYGOTE; MICE; MICE, INBRED C57BL; STEM CELLS;

EID: 70449372852     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007500     Document Type: Article

References (28)

1. Bilodeau M, Girard S, Hebert J, Sauvageau G (2007) A retroviral strategy that efficiently creates chromosomal deletions in mammalian cells. Nat Methods 4: 263-268.
2. Lee MJ, Kim JY, Suk K, Park JH (2004) Identification of the hypoxia-inducible factor 1 alpha-responsive HGTD-P gene as a mediator in the mitochondrial apoptotic pathway. Mol Cell Biol 24: 3918-3927.
3. Kuhn RM, Karolchik D, Zweig AS, Wang T, Smith KE, et al. (2009) The UCSC Genome Browser Database: update 2009. Nucleic Acids Res 37: D755-761.
4. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, et al. (2002) Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci U S A 99: 4465-4470.
5. Cho YE, Kim JY, Kim YW, Park JH, Lee S (2009) Expression and prognostic significance of human growth and transformation-dependent protein in gastric carcinoma and gastric adenoma. Hum Pathol 40: 975-981.
6. Zavasnik-Bergant T (2008) Cystatin protease inhibitors and immune functions. Front Biosci 13: 4625-4637.
7. Turk V, Stoka V, Turk D (2008) Cystatins: biochemical and structural properties, and medical relevance. Front Biosci 13: 5406-5420.
8. Roper RJ, McAllister RD, Biggins JE, Michael SD, Min SH, et al. (2003) Aod1 controlling day 3 thymectomy-induced autoimmune ovarian dysgenesis in mice encompasses two linked quantitative trait loci with opposing allelic effects on disease susceptibility. J Immunol 170: 5886-5891.
9. Mlinaric-Rascan I, Asa SL, Siminovitch KA (1994) Increased expression of the stefin A cysteine proteinase inhibitor occurs in the myelomonocytic cell-infiltrated tissues of autoimmune motheaten mice. Am J Pathol 145: 902-912.
10. Luo A, Kong J, Hu G, Liew CC, Xiong M, et al. (2004) Discovery of Ca2+-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray. Oncogene 23: 1291-1299.
11. Russo A, Bazan V, Migliavacca M, Zanna I, Tubiolo C, et al. (2000) Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma. Clin Cancer Res 6: 178-184.
12. Werle B, Schanzenbacher U, Lah TT, Ebert E, Julke B, et al. (2006) Cystatins in non-small cell lung cancer: tissue levels, localization and relation to prognosis. Oncol Rep 16: 647-655.
13. Roesch-Ely M, Nees M, Karsai S, Ruess A, Bogumil R, et al. (2007) Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer. Oncogene 26: 54-64.
14. Primoz S, Oblak I, Gale N, Smid L, Kos J (2008) Cysteine cathepsins B and L and their inhibitors stefins A and B in carcinoma of the oropharynx: immunohistochemical study. Histopathology 53: 612-614.
15. Parker BS, Ciocca DR, Bidwell BN, Gago FE, Fanelli MA, et al. (2008) Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer. J Pathol 214: 337-346.
16. Li W, Ding F, Zhang L, Liu Z, Wu Y, et al. (2005) Overexpression of stefin A in human esophageal squamous cell carcinoma cells inhibits tumor cell growth, angiogenesis, invasion, and metastasis. Clin Cancer Res 11: 8753-8762.
17. Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder JC (1993) Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci U S A 90: 8424-8428.
18. Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM, et al. (1998) Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J 17: 3714-3725.
19. Bijl J, Krosl J, Lebert-Ghali CE, Vacher J, Mayotte N, et al. (2008) Evidence for Hox and E2A-PBX1 collaboration in mouse T-cell leukemia. Oncogene 27: 6356-6364.
20. Sauvageau G, Thorsteinsdottir U, Hough MR, Hugo P, Lawrence HJ, et al. (1997) Overexpression of HOXB3 in hematopoietic cells causes defective lymphoid development and progressive myeloproliferation. Immunity 6: 13-22.
21. Maglott D, Ostell J, Pruitt KD, Tatusova T (2005) Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res 33: D54-58.
22. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947-2948.
23. Abascal F, Zardoya R, Posada D (2005) ProtTest: selection of best-fit models of protein evolution. Bioinformatics 21: 2104-2105.
24. Guindon S, Gascuel O (2003) A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 52: 696-704.
25. Kiel MJ, Yilmaz OH, Iwashita T, Terhorst C, Morrison SJ (2005) SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121: 1109-1121.
26. Zavasnik-Bergant T, Turk B (2006) Cysteine cathepsins in the immune response. Tissue Antigens 67: 349-355.
27. Sauvageau M, Miller M, Lemieux S, Lessard J, Hebert J, et al. (2008) Quantitative expression profiling guided by common retroviral insertion sites reveals novel and cell type specific cancer genes in leukemia. Blood 111: 790-799.
28. Jackson RJ, Engelman RW, Coppola D, Cantor AB, Wharton W, et al. (2003) p21Cip1 nullizygosity increases tumor metastasis in irradiated mice. Cancer Res 63: 3021-3025.